FindMyRecallSubscribe
Class I: serious health riskCompleted

Sandoz Enoxaparin Sodium Injection Recall

Enoxaparin Sodium Injection, USP, 40 mg/0

Sandoz Inc · Princeton, NJ

Risk level
Class I
Reported by FDA
Dec 8, 2021
Recall ID
D-0286-2022
Check your lot numberHow we source this data

Summary

Sandoz recalled Enoxaparin Sodium Injection starting Nov 17, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0286-2022 on Dec 8, 2021. Reason: Temperature Abuse; temperature excursion during shipping. Status: Completed.

Why it was recalled

Temperature Abuse; temperature excursion during shipping

Product description

Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64

Lot numbers, UPCs & expiration codes

Lot #SAB06761A, exp 04/2023

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0286-2022
Classification
Class I
Status
Completed
Recall initiated
Nov 17, 2021
FDA report date
Dec 8, 2021
Quantity
45,036 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-0286-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Completed
Country
United States
Event ID
89033
Address
100 College Rd W
Code information
Lot #SAB06761A, exp 04/2023
Postal code
08540-6604
Report date
Dec 8, 2021
Product type
Drugs
Recall number
D-0286-2022
Classification
Class I
Recalling firm
Sandoz Inc
Product quantity
45,036 cartons
Reason for recall
Temperature Abuse; temperature excursion during shipping
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64
Distribution pattern
Nationwide in the US
Recall initiation date
Nov 17, 2021
Initial firm notification
Letter
Center classification date
Dec 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0286-2022, published Dec 8, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls